To view the clinical trials Valley currently has available, please use the search field or select a clinical specialty from the drop-down list below. Be sure to check back frequently, as we are always adding new studies.
For more information about any of our clinical trials, please email [email protected] or call 201-447-8453. (For cancer clinical trials, please call 201-634-5792.)
A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation (ADVANTAGE AF)
Principal Investigator(s): Suneet Mittal, MD
Status: Closed to Enrollment, Patients in Follow-Up
BATwire Implant Kit
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
Pragmatic Randomized Clinical Trial of Early Dronedarone Versus Usual Care to Change and Improve Outcomes in Persons With First-Detected Atrial Fibrillation
Principal Investigator(s): Dan L. Musat, MD
Status: Open and enrolling
A Randomized Controlled Trial of Mild vs. Moderate Hypothermia on Patient Outcomes in Aortic Hemiarch Surgery With Anterograde Cerebral Perfusio
Principal Investigator(s): Habib Jabagi, MD
Status: Open and enrolling
A Randomized, Comparative Effectiveness Study of Staged Complete Revascularization With Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs Medical Management Alone in Patients With Symptomatic Aortic Valve Stenosis Undergoing Elective Transfemoral Transcatheter Aortic Valve Replacement: The COMPLETE TAVR Study
Principal Investigator(s): Rajiv Tayal, MD, MPH
Status: Open and enrolling
Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry (CONFIRM2)
Principal Investigator(s): Himanshu Gupta, MD
Status: Open and enrolling
The purpose of this study is to evaluate the association between complex patterns of device-detected AF and other summary and episodic measurements collected by the LINQ ICM device and AF-related healthcare utilization, quality of life, AF-related symptoms, and specific clinical outcomes in patients with a market-released LINQ ICM.
Principal Investigator(s): Dan L. Musat, MD
Status: Open and enrolling
FACTORS ASSOCIATED WITH RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE PATIENTS WITH NON-LBBB ECG PATTERN
Principal Investigator(s): Dan L. Musat, MD
Status: Open and enrolling
His Bundle Corrective Pacing in Heart Failure (HIS-CRT)
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease.
Principal Investigator(s): Joel S. Landzberg, MD
Status: Open and enrolling